BioSig Technologies Inc BSGM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BSGM is a good fit for your portfolio.
News
-
BioSig Engages Consulting Firm for Business Model Strategies
-
BioSig Announces Reduction of its Workforce
-
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
-
BioSig Announces Reverse Stock Split
-
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
Trading Information
- Previous Close Price
- $1.48
- Day Range
- $1.26–1.46
- 52-Week Range
- $0.26–16.50
- Bid/Ask
- $1.28 / $1.35
- Market Cap
- $14.78 Mil
- Volume/Avg
- 154,915 / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 604.58
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
BioSig Technologies Inc is a commercial-stage medical device company with an advanced digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), It is committed to addressing healthcare’s biggest priorities saving time, saving costs, and saving lives. Its first product, the PURE EP System, is an FDA-cleared non-invasive class II device consisting of a unique combination of hardware and software designed to provide unprecedented signal clarity and precision for real-time visualization of intracardiac signals paving the way for personalized patient care.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 47
- Website
- https://www.biosig.com
Comparables
Valuation
|
Metric
|
BSGM
|
EMBC
|
MMSI
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 3.45 | 24.64 |
Price/Book Value | — | — | 3.57 |
Price/Sales | 604.58 | 0.56 | 3.44 |
Price/Cash Flow | — | 5.39 | 20.12 |
Price/Earnings
BSGM
EMBC
MMSI
Financial Strength
|
Metric
|
BSGM
|
EMBC
|
MMSI
|
|---|---|---|---|
Quick Ratio | 0.07 | 1.55 | 3.81 |
Current Ratio | 0.12 | 2.20 | 5.45 |
Interest Coverage | — | 1.59 | 8.07 |
Quick Ratio
BSGM
EMBC
MMSI
Profitability
|
Metric
|
BSGM
|
EMBC
|
MMSI
|
|---|---|---|---|
Return on Assets (Normalized) | −511.66% | 12.52% | 9.43% |
Return on Equity (Normalized) | — | — | 14.77% |
Return on Invested Capital (Normalized) | −4,547.55% | 30.00% | 11.47% |
Return on Assets
BSGM
EMBC
MMSI
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Wjgkxdw | Jdjbpl | $185.5 Bil | |
SYK
| Stryker Corp | Dkmlgpphz | Pwzq | $128.2 Bil | |
MDT
| Medtronic PLC | Cdfvypyq | Vthcm | $106.7 Bil | |
BSX
| Boston Scientific Corp | Xbwnndnr | Xsszlj | $99.0 Bil | |
DXCM
| DexCom Inc | Tpqwkvwhk | Xckwy | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Mqhzyvprp | Vhlgvgk | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Kkhnjstww | Lbvp | $24.9 Bil | |
ALGN
| Align Technology Inc | Gkjrdphk | Xdlyn | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Mmqftpcb | Xdnjdq | $18.9 Bil | |
PODD
| Insulet Corp | Cxmljftb | Hvncpn | $11.7 Bil |